Processa Pharmaceuticals, Inc. (PCSA) stock
PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$1.73+0.01 (+0.58%)
Close on Nov 17, 2026Market cap $4.83MP/E –Yield –
Processa Pharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Processa Pharmaceuticals's total debt was $230.00K at Dec 31, 2018. For fiscal 2018 it was $230.00K, down 90.6% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $230.00K | -90.6% |
| FY2017 | Dec 31, 2017 | $2.45M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2018 | Dec 31, 2018 | $230.00K | – |
| Q4 FY2017 | Dec 31, 2017 | $2.45M | – |
See a number that looks wrong?